Genpact Limited
G · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,291,257 | $1,254,418 | $1,214,926 | $1,248,741 |
| % Growth | 2.9% | 3.3% | -2.7% | – |
| Cost of Goods Sold | $821,601 | $804,350 | $785,932 | $802,969 |
| Gross Profit | $469,656 | $450,068 | $428,994 | $445,772 |
| % Margin | 36.4% | 35.9% | 35.3% | 35.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $262,105 | $266,393 | $241,084 | $249,157 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $15,909 | $4,273 | $4,208 | $6,441 |
| Operating Expenses | $278,014 | $270,666 | $245,292 | $255,598 |
| Operating Income | $191,642 | $179,402 | $183,702 | $190,174 |
| % Margin | 14.8% | 14.3% | 15.1% | 15.2% |
| Other Income/Exp. Net | -$2,290 | -$2,664 | -$8,479 | -$7,626 |
| Pre-Tax Income | $189,352 | $176,738 | $175,223 | $182,548 |
| Tax Expense | $43,521 | $44,022 | $44,370 | $40,633 |
| Net Income | $145,831 | $132,716 | $130,853 | $141,915 |
| % Margin | 11.3% | 10.6% | 10.8% | 11.4% |
| EPS | 0.84 | 0.76 | 0.75 | 0.8 |
| % Growth | 10.5% | 1.3% | -6.3% | – |
| EPS Diluted | 0.83 | 0.75 | 0.73 | 0.79 |
| Weighted Avg Shares Out | 175,700 | 174,611 | 175,528 | 178,386 |
| Weighted Avg Shares Out Dil | 176,105 | 177,052 | 178,435 | 180,437 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $4,534 | $6,255 | $9,575 |
| Interest Expense | $12,785 | $18,019 | $17,701 | $20,622 |
| Depreciation & Amortization | $27,275 | $21,514 | $21,212 | $24,444 |
| EBITDA | $229,412 | $216,271 | $214,136 | $227,614 |
| % Margin | 17.8% | 17.2% | 17.6% | 18.2% |